BHCM
ACHV icon

Brevan Howard Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Brevan Howard Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Buy
+54,508
New +$242K ﹤0.01% 1947
2025
Q3 		– Sell
-64,348
Closed -$145K – 1905
2025
Q2 		$145K Buy
+64,348
New +$183K ﹤0.01% 1758

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's ACHV Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Achieve Life Sciences (ACHV) in Q1 2026: 54,508 shares worth $160K. The stake represents ﹤0.01% of the portfolio and ranks #1947 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ACHV as recently as Q2 2025.

Brevan Howard Capital Management first reported a position in ACHV in Q2 2025 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Brevan Howard Capital Management held 54,508 shares of Achieve Life Sciences worth $160K as of Q1 2026.
  • Achieve Life Sciences was a new Brevan Howard Capital Management position in Q1 2026.
  • Achieve Life Sciences made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1947 holding.
  • Brevan Howard Capital Management first reported a position in Achieve Life Sciences in Q2 2025 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.